HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magdalena Krupa Selected Research

JV 1-53

4/2002Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Magdalena Krupa Research Topics

Disease

11Neoplasms (Cancer)
01/2017 - 02/2002
6Prostatic Neoplasms (Prostate Cancer)
02/2011 - 02/2002
5Carcinoma (Carcinomatosis)
10/2002 - 02/2002
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Communicable Diseases (Infectious Diseases)
06/2011
1Osteosarcoma (Osteogenic Sarcoma)
10/2002
1Sarcoma (Soft Tissue Sarcoma)
10/2002
1Ewing Sarcoma (Sarcoma, Ewing)
10/2002
1Ovarian Neoplasms (Ovarian Cancer)
10/2002
1Adenocarcinoma
10/2002
1Body Weight (Weight, Body)
02/2002

Drug/Important Bio-Agent (IBA)

8Messenger RNA (mRNA)IBA
10/2002 - 02/2002
5Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
10/2002 - 04/2002
3Insulin-Like Growth Factor I (IGF-1)IBA
10/2002 - 04/2002
3AndrogensIBA
08/2002 - 02/2002
2Biological ProductsIBA
06/2011 - 04/2008
2Immunologic Factors (Immunomodulators)IBA
06/2011 - 04/2008
2VaccinesIBA
06/2011 - 04/2008
2Insulin-Like Growth Factor II (Somatomedin A)IBA
10/2002 - 08/2002
2JV 1-38IBA
10/2002 - 08/2002
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2002 - 02/2002
2Growth Hormone (Somatotropin)IBA
10/2002 - 08/2002
2somatotropin releasing hormone receptorIBA
10/2002 - 06/2002
2AN 204 (AN 201)IBA
10/2002 - 02/2002
2AN 207IBA
10/2002 - 02/2002
2Epidermal Growth Factor (EGF)IBA
10/2002 - 03/2002
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2002 - 02/2002
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2002 - 06/2002
2Proteins (Proteins, Gene)FDA Link
10/2002 - 03/2002
2LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
10/2002 - 02/2002
2Protein Isoforms (Isoforms)IBA
10/2002 - 06/2002
2vapreotideIBA
08/2002 - 04/2002
1EnzymesIBA
01/2017
1Gold Sodium Thiomalate (Sodium Aurothiomalate)IBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1PKC-3 proteinIBA
01/2017
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1Recombinant DNA (Recombinant DNA Research)IBA
02/2011
1DNA (Deoxyribonucleic Acid)IBA
02/2011
1Cancer VaccinesIBA
02/2011
1AntigensIBA
02/2011
1Methylnitronitrosoguanidine (MNNG)IBA
10/2002
1LigandsIBA
10/2002
1ErbB Receptors (EGF Receptor)IBA
10/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2002
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
08/2002
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
04/2002
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
04/2002
1JV 1-52IBA
04/2002
1JV 1-53IBA
04/2002
1Estrogens (Estrogen)FDA Link
03/2002
1Peptides (Polypeptides)IBA
03/2002
1BombesinIBA
03/2002
1Gastrin-Releasing PeptideIBA
03/2002
1Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
03/2002
1Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
03/2002
1Oncogene Proteins (Oncogene Protein)IBA
03/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2002

Therapy/Procedure

5Therapeutics
01/2017 - 02/2002
2Drug Therapy (Chemotherapy)
10/2002 - 02/2002